2023
Assessing and managing frailty in advanced heart failure: An International Society for Heart and Lung Transplantation consensus statement
Denfeld Q, Jha S, Fung E, Jaarsma T, Maurer M, Reeves G, Afilalo J, Beerli N, Bellumkonda L, De Geest S, Gorodeski E, Joyce E, Kobashigawa J, Mauthner O, McDonagh J, Uchmanowicz I, Dickson V, Lindenfeld J, Macdonald P. Assessing and managing frailty in advanced heart failure: An International Society for Heart and Lung Transplantation consensus statement. The Journal Of Heart And Lung Transplantation 2023, 43: 1-27. PMID: 38099896, DOI: 10.1016/j.healun.2023.09.013.Peer-Reviewed Original ResearchAdvanced heart failureDefinition of frailtyHeart failureConsensus statementOverview of frailtyAssessment of frailtyMeasurement of frailtyCritical evidence gapsHF cliniciansFrailty assessmentGeriatric conditionsNonsurgical interventionsClinical practiceEvidence gapsFrailtyPsychological impairmentPhysical performanceClinical implementationPatientsInternational SocietyComorbiditiesPrevious studiesSarcopeniaAssessmentFailureTCT-214 Right Ventricular Function in Patients Undergoing Impella-Assisted High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study
Rommel K, Bonnet G, Bellumkonda L, Zhang Y, Lansky A, Redfors B, Granada J, Bharadwaj A, Basir B, Patel R, O’Neill W, Burkhoff D. TCT-214 Right Ventricular Function in Patients Undergoing Impella-Assisted High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study. Journal Of The American College Of Cardiology 2023, 82: b82-b83. DOI: 10.1016/j.jacc.2023.09.221.Peer-Reviewed Original ResearchDual organ transplantation: when heart alone is not enough
Nuqali A, Bellumkonda L. Dual organ transplantation: when heart alone is not enough. Current Opinion In Organ Transplantation 2023, 28: 370-375. PMID: 37582057, DOI: 10.1097/mot.0000000000001093.Peer-Reviewed Original ResearchConceptsDual-organ transplantationOrgan transplantationPatient selectionBetter long-term outcomesDual organ transplantsSingle organ transplantationTransplant center experienceLong-term outcomesAdvanced disease processLong-term managementPosttransplant outcomesCenter experienceImmunological advantageOrgan transplantsDisease processPartial toleranceSecond organPatientsTransplantationLack of standardizationOutcomesOrgansUrgent needTransplantShort-Term Outcomes Among Aortic Valve Stenosis Patients Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention
Velagapudi P, Abu-Much A, Bellumkonda L, Maini A, Redfors B, Lansky A, Li Y, Grines C, Batchelor W, O'Neill W, Cohen D. Short-Term Outcomes Among Aortic Valve Stenosis Patients Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention. Cardiovascular Revascularization Medicine 2023, 53: s110. DOI: 10.1016/j.carrev.2023.05.253.Peer-Reviewed Original ResearchIn-Hospital Observation on Oral Diuretics After Treatment for Acute Decompensated Heart Failure: Evaluating the Utility
Ivey-Miranda J, Rao V, Cox Z, Moreno-Villagomez J, Mahoney D, Maulion C, Bellumkonda L, Turner J, Collins S, Wilson F, Krumholz H, Testani J. In-Hospital Observation on Oral Diuretics After Treatment for Acute Decompensated Heart Failure: Evaluating the Utility. Circulation Heart Failure 2023, 16: e010206. PMID: 36896716, PMCID: PMC10186250, DOI: 10.1161/circheartfailure.122.010206.Peer-Reviewed Original ResearchConceptsAcute decompensated heart failureDecompensated heart failureDiuretic responseDiuretic dosingOral diureticsHeart failureMulticenter cohortHospital observationLower readmission ratesNet fluid balanceDays postdischargeReadmission ratesHospital readmissionUrine outputReadmission riskFluid statusFluid balanceHospital measuresDose selectionCohortProvider decisionsWeight changeReadmissionDiureticsPatientsCRT-700.34 Short-Term Outcomes Among Aortic Valve Stenosis Patients Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention
Velagapudi P, Abu-Much A, Bellumkonda L, Maini A, Redfors B, Lansky A, Li Y, Grines C, Batchelor W, O'Neill W, Cohen D. CRT-700.34 Short-Term Outcomes Among Aortic Valve Stenosis Patients Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention. JACC Cardiovascular Interventions 2023, 16: s92-s93. DOI: 10.1016/j.jcin.2023.01.291.Peer-Reviewed Original ResearchImprovement in Renal Function During the Treatment of Acute Decompensated Heart Failure: Relationship With Markers of Renal Tubular Injury and Prognostic Importance
Natov P, Ivey-Miranda J, Cox Z, Moreno-Villagomez J, Maulion C, Bellumkonda L, Shlipak M, Estrella M, Borlaug B, Rao V, Testani J. Improvement in Renal Function During the Treatment of Acute Decompensated Heart Failure: Relationship With Markers of Renal Tubular Injury and Prognostic Importance. Circulation Heart Failure 2023, 16: e009776. PMID: 36700431, PMCID: PMC10150783, DOI: 10.1161/circheartfailure.122.009776.Peer-Reviewed Original ResearchConceptsAcute decompensated heart failureDecompensated heart failureStable renal functionGlomerular filtration rateRenal functionRenal tubular injuryHeart failureTubular injuryKIM-1Filtration rateRenal tubular injury markersTubular injury markersRenal function groupCumulative urine outputCardiorenal dysfunctionDiuretic dosesInjury markersWorse survivalWorsened survivalUrine outputDecongestive therapyPrognostic importanceAdverse outcomesLower admissionPatients
2020
A Systematic Review of Cardiogenic Shock in the Setting of Severe Aortic Stenosis: Prevalence, Management, and Outcomes
Essa M, Essa M, Berardi C, Aneni E, Fleming J, Trejo-Paredes M, Bellumkonda L, F. Faridi K, Sugeng L. A Systematic Review of Cardiogenic Shock in the Setting of Severe Aortic Stenosis: Prevalence, Management, and Outcomes. American Journal Of Cardiovascular Research 2020, 1-9. DOI: 10.31487/nl.ajcr.2020.01.02.Peer-Reviewed Original ResearchBalloon aortic valvuloplastySevere aortic stenosisSurgical valve replacementCardiogenic shockAortic stenosisSystematic reviewCommon valvular heart diseaseProcedure-related complicationsValvular heart diseaseTranscatheter aortic valveHospital mortalityAortic valvuloplastyValve replacementPrimary outcomeCirculatory supportFatal conditionAortic valveHeart diseaseStudy protocolBetter outcomesPatientsMedical emergencyStenosisAdditional outcomesMortality
2014
(168) Acute Rejection and Graft Failure Drive Worse Outcomes Among Peripartum Cardiomyopathy (PPCM) Patients Undergoing Heart Transplant (HT) in the US: A UNOS Analysis
Jacoby D, Jawitz O, Bellumkonda L, Bonde P. (168) Acute Rejection and Graft Failure Drive Worse Outcomes Among Peripartum Cardiomyopathy (PPCM) Patients Undergoing Heart Transplant (HT) in the US: A UNOS Analysis. The Journal Of Heart And Lung Transplantation 2014, 33: s67. DOI: 10.1016/j.healun.2014.01.214.Peer-Reviewed Original Research
2006
The Anti‐platelet Effect of Aspirin in Patients with End Stage Renal Disease
Faheem O, Shah A, Haider J, Schumacher J, Liang T, Azrin M, Bellumkonda L, Walsh S, Kaplan A, Liang B. The Anti‐platelet Effect of Aspirin in Patients with End Stage Renal Disease. The FASEB Journal 2006, 20: a1139-a1139. DOI: 10.1096/fasebj.20.5.a1139.Peer-Reviewed Original ResearchAnti-platelet effectsRenal failurePlatelet aggregationControl patientsArachidonic acidEnd-stage renal diseaseAnti-platelet responseGreater platelet aggregationStage renal diseaseAgonist-induced platelet aggregationRenal failure patientsASA ingestionASA resistanceAspirin resistanceVascular eventsFailure patientsRenal diseaseControl subjectsPatientsPlatelet agonistsWhole bloodAgonistsASAVariable responseSubjects